Stage Iii Renal Cell Cancer: Disease Bioinformatics
Kidney cancer, also known as renal cell cancer, begins in the kidneys and is the common among adults and children (many children develop a specific kind of kidney cancer called Wilms' tumor). Risk of developing kidney cancer increases with age, smoking, being male, obesity, hypertension, exposure to chemicals, von hippel-lindau disease, treatment for kidney failure, and a family history. Kidney cancer is most commonly treated with surgery, cryoablation, radiofrequency ablation, drug therapy, radiation therapy, and targeted therapy. In Stage III kidney cancer, the tumor has grown into a major vein or in the tissue around the kidney. At this point, it is not growing into the adrenal gland, beyond gerota's fascia, or to the lymph nodes or distant organs. Additionally, the tumor may be any size and outside the kidney and to nearby lymph nodes, but it has not relocated to gerota's fascia, distant sites, or organs.
Stage Iii Renal Cell Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iii Renal Cell Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1060 products for the study of Stage Iii Renal Cell Cancer that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.